Efficacy and safety of the R2-MTX regimen in primary central nervous system lymphoma (PCNSL): a single-center retrospective analysis
Our results underscore the therapeutic potential of the R2-MTX regimen in managing newly diagnosed PCNSL patients. Further prospective studies with larger patient cohorts are imperative to solidify these preliminary findings.
Authors
- Li Xie (ORCID: https://orcid.org/0000-0002-8675-7623)
- Ming Jiang (ORCID: https://orcid.org/0000-0002-6426-4107)
- Lijie Liang
- Xue Meng (ORCID: https://orcid.org/0000-0003-1222-3917)
- You Feng
- Na Li (ORCID: https://orcid.org/0009-0006-9447-6908)
Institutions
- Sichuan University (CN)
- West China Medical Center of Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Sichuan Cancer Hospital (CN)
- Chongqing Cancer Hospital (CN)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1007/s00432-025-06205-x
- Citations
- 1
- Primary Topic
- CNS Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.39